Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
12 Mar 2022
// N.P. Taylor FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/histogen-seeks-tear-covid-19-rd-pact-and-go-solo-accuses-amerimmune-failing-push-phase-2
16 Aug 2021
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/histogen-amerimmune-covid-drug/
16 Aug 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/08/16/2281050/0/en/Histogen-and-Amerimmune-Announce-Additional-Findings-from-its-Phase-1-Study-of-Emricasan-in-Mild-Symptomatic-COVID-19-Patients.html
18 May 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/05/19/2232422/0/en/Histogen-and-Amerimmune-Report-Publication-on-Emricasan-in-COVID-19.html
16 Mar 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/03/16/2193562/0/en/Histogen-and-Amerimmune-Announce-First-Patient-Dosed-in-Phase-1-Study-of-Emricasan-in-Symptomatic-COVID-19-Patients.html#:~:text=(NASDAQ%3A%20HSTO)%20and%20Amerimmune,site%20for%20the%20study%20conduct.
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?